Dublin, April 08, 2016 -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "Cytogenetics - Technologies, Markets and Companies" to their offering.
This report deals with cytogenetics in a broader sense rather than the classical use mainly to describe the chromosome structure and identify abnormalities related to disease. In the age of molecular biology, it is also referred to as molecular cytogenetics. The scope of cytogenetics includes several technologies besides fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and multicolor FISH. Molecular cytogenetics includes application of nanobiotechnology, microarrays, real-time polymerase chain reaction (PCR), in vivo imaging, and single molecule detection. Bioinformatics is described briefly as it plays an important role in analyzing data from many of these technologies.
The chapter on markets provides a global perspective of the cytogenetics business in the major markets: US, Western Europe (including France, Germany, Italy, Spain, and the UK), and Japan. The total figures for the market are also broken out according to the technologies and major disease areas in which they are applied.
Markets figure are given for the year 2015 and estimates are made for the years 2020 and 2025. Advantages and limitations of various technologies have been pointed out throughout the report but this chapter includes SWOT (Strengths, Weaknesses, Opportunities and Threats) analysis of some of the competing technologies including the following: conventional FISH, innovative FISH technologies, PCR-based assays, and single molecule imaging. Unfulfilled needs in cytogenetics market are depicted graphically. Among various technologies, FISH is most advanced and less opportunities for further development than single molecule detection, which is in infancy and has more future potential.
The report includes summary profiles of 69 companies relevant to cytogenetics along with their 80 collaborations. Companies developing innovative technologies as well as those supplying equipment/services/reagents are identified.The report text is supplemented with 27 Tables and 9 figures. Selected 200 references are included in the bibliography.
Key Topics Covered:
Executive Summary
1. Introduction
2. Technologies used for cytogenetics
3. Fluorescent In Situ Hybridization
4. Genomic Technologies relevant to Cytogenetics
5. Molecular Imaging & Single Molecular Detection
6. Role of Nanobiotechnology in Cytogenetics
7. Biomarkers and Cytogenetics
8. Applications of Cytogenetics
9. Cancer Cytogenetics
10. Cytogenetics Markets
11. Companies
12. References
For more information visit http://www.researchandmarkets.com/research/h9dqhz/cytogenetics
Source: Jain PharmaBiotech
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Genomics


Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S.
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling
SK Hynix Shares Hit Record High as AI Memory Demand Fuels Semiconductor Rally
Trump Weighs Blocking Exxon Investment as Venezuela Deemed “Uninvestable”
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks
EU Orders Elon Musk’s X to Preserve Grok AI Data Amid Probe Into Illegal Content
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny
xAI Cash Burn Highlights the High Cost of Competing in Generative AI
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook
Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer 



